Chen, Y.-W.; Tucker, M.D.; Brown, L.C.; Yasin, H.A.; Ancell, K.K.; Armstrong, A.J.; Beckermann, K.E.; Davis, N.B.; Harrison, M.R.; Kaiser, E.G.;
et al. The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma. Cancers 2022, 14, 3830.
https://doi.org/10.3390/cancers14153830
AMA Style
Chen Y-W, Tucker MD, Brown LC, Yasin HA, Ancell KK, Armstrong AJ, Beckermann KE, Davis NB, Harrison MR, Kaiser EG,
et al. The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma. Cancers. 2022; 14(15):3830.
https://doi.org/10.3390/cancers14153830
Chicago/Turabian Style
Chen, Yu-Wei, Matthew D. Tucker, Landon C. Brown, Hesham A. Yasin, Kristin K. Ancell, Andrew J. Armstrong, Kathryn E. Beckermann, Nancy B. Davis, Michael R. Harrison, Elizabeth G. Kaiser,
and et al. 2022. "The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma" Cancers 14, no. 15: 3830.
https://doi.org/10.3390/cancers14153830
APA Style
Chen, Y.-W., Tucker, M. D., Brown, L. C., Yasin, H. A., Ancell, K. K., Armstrong, A. J., Beckermann, K. E., Davis, N. B., Harrison, M. R., Kaiser, E. G., McAlister, R. K., Schaffer, K. R., Wallace, D. E., George, D. J., Rathmell, W. K., Rini, B. I., & Zhang, T.
(2022). The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma. Cancers, 14(15), 3830.
https://doi.org/10.3390/cancers14153830
